Suppr超能文献

Rho 激酶依赖性 GPR39 脱敏;GPCR 下调的独特机制。

Rho kinase-dependent desensitization of GPR39; a unique mechanism of GPCR downregulation.

机构信息

Biomolecular Research Laboratories, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.

Biomolecular Research Laboratories, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.

出版信息

Biochem Pharmacol. 2017 Sep 15;140:105-114. doi: 10.1016/j.bcp.2017.06.115. Epub 2017 Jun 12.

Abstract

GPR39, a G-protein-coupled receptor activated by zinc, reportedly activates multiple intracellular signaling pathways via Gs, Gq, G12/13, and β-arrestin, but little is known about downregulation of the receptor upon its activation. To our knowledge, this is the first report on the mechanism of feedback regulation of GPR39 function determined in GPR39-expressing HEK293 cells (HEK293-GPR39) as a model cell system. In HEK293-GPR39 cells, GPR39-C3, which is a positive allosteric modulator, activated cAMP production (downstream of Gs), IP1 accumulation (downstream of Gq), SRF-RE-dependent transcription (downstream of G12/13), and β-arrestin recruitment. GPR39-C3 induced dose- and time-dependent loss of response in cAMP production by second challenge of the compound. This functional desensitization was blocked by the Rho kinase (ROCK) inhibitor, Y-27632, but not by Gq or Gs-pathway inhibitors or inhibition of β-arrestin recruitment. In the receptor localization assay, GPR39-C3 induced internalization of GFP-tagged GPR39. This internalization was also inhibited by Y-27632, which suggested that ROCK activation is critical for internalization and desensitization of GPR39. A novel biased GPR39 positive allosteric modulator, 5-[2-[(2,4-dichlorophenyl)methoxy]phenyl]-2,2-dimethyl-1,3,5,6-tetrahydrobenzo[a]phenanthridin-4-one (GSB-118), which activated cAMP responses and β-arrestin recruitment but showed no effect on SRF-RE-dependent transcription, did not induce desensitization. These results revealed a unique mechanism of desensitization of GPR39.

摘要

GPR39 是一种锌激活的 G 蛋白偶联受体,据报道,它通过 Gs、Gq、G12/13 和β-arrestin 激活多种细胞内信号通路,但对于受体激活后的下调知之甚少。据我们所知,这是首次在表达 GPR39 的 HEK293 细胞(HEK293-GPR39)作为模型细胞系统中报道 GPR39 功能反馈调节的机制。在 HEK293-GPR39 细胞中,GPR39-C3 是一种正变构调节剂,可激活 cAMP 产生(Gs 下游)、IP1 积累(Gq 下游)、SRF-RE 依赖性转录(G12/13 下游)和β-arrestin 募集。GPR39-C3 诱导化合物第二次刺激时 cAMP 产生的剂量和时间依赖性反应丧失。这种功能脱敏被 Rho 激酶(ROCK)抑制剂 Y-27632 阻断,但不受 Gq 或 Gs 通路抑制剂或β-arrestin 募集抑制的影响。在受体定位测定中,GPR39-C3 诱导 GFP 标记的 GPR39 内化。这种内化也被 Y-27632 抑制,这表明 ROCK 激活对于 GPR39 的内化和脱敏至关重要。一种新型的偏向性 GPR39 正变构调节剂,5-[2-[(2,4-二氯苯基)甲氧基]苯基]-2,2-二甲基-1,3,5,6-四氢苯并[a]菲啶-4-酮(GSB-118),可激活 cAMP 反应和β-arrestin 募集,但对 SRF-RE 依赖性转录没有影响,不诱导脱敏。这些结果揭示了 GPR39 脱敏的独特机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验